Did Gilead's remdesivir flop a Chinese trial? Analysts beg to differ

Did Gilead's remdesivir flop a Chinese trial? Analysts beg to differ

Source: 
Fierce Biotech
snippet: 

Another day, another leak—or so it seems for Gilead’s COVID-19 hopeful remdesivir. This time, the World Health Organization accidentally revealed data from a study in China showing that the treatment neither improved patients’ condition nor tamped down on the amount of virus in their blood, Financial Times reported, calling the trial a “flop.”